Asahi Kasei Pharma Open Innovation 2023

Asahi Kasei Pharma is publicly calling for new proposals related to drug discovery research and offer up to US$ 200'000 funding per year, up to 3 years, for each selected proposal, see press release.

The application period ends at 8:00 a.m. GMT on February 28, 2023.

Proposals are solicited concerning new drug seeds (drug target and drug candidate) and technologies in the therapeutic fields of autoimmune disease, renal disease, neurodegenerative disease, bone disease and pain, and drug discovery platform technology.

Applications can be submitted here and further information is available here.

January 16, 2023